| SOPA Images/LightRocket via Getty Images Key Takeaways Amgen is buying Horizon Therapeutics for just over $26 billion, or $116.50 per share. Horizon has two major drugs, Tepezza and Krystexxa, a thy...
Tag: amgen stock
Will Amgen Stock Skyrocket Through FDA Trials?
| Getty Images Key Takeaways Amgen announced positive results from a phase I trial of its new obesity drug, AMG 133. After its earnings announcement and the trial results, Amgen stock rose more than 5...